Armistice Capital
Armistice Capital LLC is a New York-based hedge fund that specializes in value-oriented and event-driven investment strategies. The firm primarily focuses on opportunities within the health care and consumer sectors, employing a disciplined approach to identify and capitalize on undervalued assets. Armistice Capital emphasizes a thorough analysis of market trends and company fundamentals to drive investment decisions, aiming to deliver significant returns for its clients.
Top Stages
Past deals in Lyon
Adocia
Post in 2025
Adocia is a clinical-stage biotechnology company based in Lyons, France, founded in 2005 and known for its focus on tissue regeneration. The company specializes in developing formulations of approved therapeutic proteins and peptides aimed at treating diabetes and other metabolic diseases. Adocia has created a proprietary technology platform called Biochaperone, which enhances the effectiveness of these therapeutic proteins. Its clinical pipeline includes products such as Biochaperone Lispro, Biochaperone Combo, and Biochaperone Glucagon, while its pre-clinical pipeline features BioChaperone LisPram, BioChaperone Glargine GLP-1, and BioChaperone Glucagon GLP1. Additionally, Adocia holds a patent portfolio that primarily addresses chronic wound healing, insulin therapy, and monoclonal antibodies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.